Nebius, Stock

Nebius Stock: A 134-Megawatt Israeli Bet Lands as the Capex Bill Climbs to $27 Billion

Published on 11/19/2026 at 19:31 | Editorial boerse-global.de
Nebius stock dropped 5.8% after a 134 MW Israel data center deal was announced alongside higher capex and a narrowed revenue outlook.
Nebius Stock: A 134-Megawatt Israeli Bet Lands as the Capex Bill Climbs to $27 Billion Illustration mit AI erstellt.

Nebius shares fell 5.8% on Thursday evening, and the reason sits at the intersection of two very different announcements. One is a fresh capacity deal in Israel; the other is the arithmetic of paying for growth that arrives later than hoped.

Mega Or has agreed with Nebius on an additional 134 megawatts of IT capacity across two sites, according to a Ctech report published today. The data centers will be built in Beit Shemesh and Masmiya, with completion expected by the end of Q2 2028 and estimated construction costs of roughly $1.6 billion. The arrangement extends an existing partnership between the two firms rather than opening a new front.

Seven Years, With an Option for Five More

Once the facilities are handed over, a seven-year service term begins. Nebius also holds an option to extend it by a further five years on the same terms. The clock starts at delivery, not at signature — a distinction that matters when the sites are still years from operation.

At Masmiya, the grid connection permit is still outstanding and its processing is currently frozen. That single caveat separates contracted capacity from usable compute, and it is the point investors should watch as the build progresses. The permit condition applies explicitly to Masmiya; extending it to both locations would overstate the risk in the agreement.

Mega Or expects an average annual net operating income of 550 million NIS from the new facilities at full occupancy, on top of an anticipated 740 million NIS from data center contracts already signed. Those figures describe the landlord's earnings, not Nebius's revenue or profit. What Nebius gets is access to additional infrastructure — value that can only be realized once the sites are delivered and actually running.

Should investors sell immediately? Or is it worth buying Nebius?

The Other Half of the Ledger

Timing is where the Israeli deal meets the broader story. Last week Nebius narrowed its revenue outlook, citing delays in third-party capacity, and simultaneously raised its investment plans. Capex guidance for 2026 now stands at about $27 billion, up from a prior range of $20 billion to $25 billion.

Higher spending paired with a more cautious top-line forecast is an uncomfortable combination, and it turns an impressive growth record into a stiffer test. It does not, on its own, mean the investment program is economically wrong. It does mean growth and delivery have to line up — announced expansion is not the same as capacity that can already be billed.

The numbers published last week show how fast the operating business has been moving. Revenue in the third quarter of 2026 reached $980.8 million, a jump of 571% year over year. Adjusted EBITDA in the same quarter came in at $465.8 million, a measure of operating results on an adjusted basis that says nothing by itself about the returns on the full investment program.

Both things can be true at once: the business is expanding sharply, and the build-out is not running as smoothly as planned. A strong quarter confirms the momentum of what is already running. Whether new infrastructure converts into revenue on schedule is a separate question — and the trimmed outlook makes that separation hard to ignore.

Citi Keeps Its Rating, Cuts Its Number

Analyst reaction captured the same tension. Citi's Tyler Radke lowered his price target on Monday to $215 from $265 while keeping a Buy rating, pointing to site delays as the reason. A constructive view on the business and a materially lower target are not contradictory; read together, they suggest patience on execution rather than a verdict on the model.

The yardstick for Nebius, then, is not the biggest possible growth rate. It is how revenue, available capacity and funding needs fit together. The quarterly figures are evidence of expansion. The narrowed guidance marks its practical limits. How well the company closes the gap between the two will decide the quality of this growth story.

Ad

Nebius Stock: New Analysis - 19 November

Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nebius analysis...

Disclaimer...
en | NL0009805522 | NEBIUS | boerse | 70537838 |